What is Fathom?
Founded in 2016 and headquartered in San Francisco, California, Fathom operates at the intersection of healthcare and artificial intelligence. The company specializes in medical coding automation, a critical process for healthcare providers to ensure accurate billing, compliance, and operational efficiency. By leveraging sophisticated algorithms and machine learning, Fathom aims to streamline the complex and often labor-intensive task of medical coding, thereby reducing errors and improving revenue cycles for healthcare organizations.
How much funding has Fathom raised?
Fathom has raised a total of $46.1M across 2 funding rounds:
Debt
$150K
Series B
$46M
Debt (2020): $150K with participation from PPP
Series B (2022): $46M led by Vituity’s Inflect Health, Alkeon Capital, Lightspeed Venture Partners, and Cedars-Sinai
Key Investors in Fathom
Alkeon Capital
Alkeon Capital Management is a venture capital firm with over two decades of experience investing in transformative companies throughout their lifecycle. They focus on growth and innovation, managing a portfolio of more than 50 private companies across multiple stages and industries. The firm operates from locations in New York, Hong Kong, San Francisco, and Florida. Alkeon aims to provide flexible investment solutions tailored to the needs of their clients.
Lightspeed Venture Partners
Lightspeed Venture Partners (lsvp.com) is a global multistage venture capital firm that raises dedicated funds and invests in early and growthstage technology companies across sectors such as enterprise software, consumer, fintech, and infrastructure, partnering with founders from seed through IPO/M&A.
Cedars-Sinai
Founded 1902 Cedars-Sinai Medical Center is a non-profit academic medical centers in the U.S., Cedars-Sinai has clinical programs ranging from primary care to specialized treatments for rare, complex and advanced illnesses. In addition, Cedars-Sinai serves the community through its Medical Network and through wide-ranging programs that improve the health of the most vulnerable residents of Los Angeles.
What's next for Fathom?
The recent major strategic investment signals a new phase of expansion and development for Fathom. With substantial backing, the company is poised to enhance its platform capabilities, broaden its market reach, and potentially explore new applications for its technology within the healthcare ecosystem. This capital infusion is expected to accelerate Fathom's mission to transform medical coding through automation, positioning it for sustained growth and leadership in the health-tech sector.
See full Fathom company page
